Effects of nicotine and vitamin E on glucose 6-phosphate dehydrogenase activity in some rat tissues in vivo and in vitro

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 20, Issue 5, 2005, Pages 497-502

  Gumustekin, Kenan ^a   Ciftci, Mehmet ^b   Coban, Abdulkadir ^b   Altikat, Sayit ^c   Aktas, Omer ^a   Gul, Mustafa ^a   Timur, Handan ^a   Dane, Senol ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

^c DUMLUPINAR UNIVERSITY   (Turkey)

Author keywords

Glucose 6 phosphate dehydrogenase; Inactivation; Inhibition; Nicotine; Rat tissues; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; HEART; IN VITRO STUDY; IN VIVO STUDY; KIDNEY HOMOGENATE; LIVER HOMOGENATE; LUNG HOMOGENATE; MUSCLE TISSUE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH; TESTIS; VITAMIN SUPPLEMENTATION;

ANIMALS; ENZYME INHIBITORS; GLUCOSEPHOSPHATE DEHYDROGENASE; NICOTINE; ORGAN SPECIFICITY; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN E;

ANIMALIA;

EID: 28244458827     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360500277384     Document Type: Article

References (64)

1. Beutler E. Glucose 6-phosphate dehydrogenase deficiency and other enzyme abnormalities. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, editors. Williams Hematology. New York: Mc Graw-Hill Co. 1995. p 564-581.
2. Deutsch J. Glucose-6-phosphate dehydrogenase. In: Bergmeyer HU, Bergmeyer J, editors. Methods of enzymatic analysis. Weinheim: VCH Verlagsgerellschaff; 1983. p 190-196.
3. Keha EE, Kufrevioglu OI. Biochemistry (in Turkish). Erzurum: Safak Yayinevi; 1997.
4. Lehninger AL, Nelson DL, Cox MM. Principles of biochemistry. New York: Worth Publishers; 1993.
5. Warnock DG. Diuretic agents. In: Katzung BG, editor. Basic and clinical pharmacology. USA: Appletion and Lange; 1989. p 183-197.
6. Berkow R. The Merck manual of diagnosis and therapy. Rahway, N.J., USA: Merck & Co. Inc; 1987.
7. Laurence DR, Bennett PN, Brown MJ. Clinical Pharmacology. Singapore: Churchill Livingstone; 1997.
8. Kayaalp SO. Medical pharmacology, in terms of rational treatment (Rasyonel tedavi yonunden tibbi farmakoloji). Ankara: Hacettepe-Tas Ltd.Sti; 1998.
9. Ames BN, Shigenaga MK, Hagen TM. Proc Natl Acad Sci USA 1993;90:7915-7922.
10. Bondy SC, Orozco J. Alcohol Alcohol 1994;29:375-383.
11. DeLeve LD, Kaplowitz N. Pharmacol Ther 1991;52:287-305.
12. Gul M, Kutay FZ, Temocin S, Hanninen O. Indian J Exp Biol 2000;38:625-634.
13. McCord JM. Clin Biochem 1993;26:351-357.
14. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford: Clarendon Press; 1989.
15. Rubin E. Alcohol Health Res World 1993;17:272-278.
16. Somani SM. Exercise, drugs and tissue specific antioxidant system. In: Somani SM, editor. Pharmacology in exercise and sports. Boca Raton FL: CRC Press; 1996. p 57-95.
17. Guemouri L, Lecomte E, Herbeth B, Pirollet P, Paille F, Siest G, Artur Y. J Stud Alcohol 1993;54:626-629.
18. Jenkins RR, Goldfarb A. Med Sci Sports Exer 1993;25:210-212.
19. Leanderson P, Tagesson C. Chem Biol Interact 1992;81:197-208.
20. Wetscher GJ, Bagchi M, Bagchi D, Perdikis G, Hinder PR, Glaser K, Hinder RA. Free Radic Biol Med 1995;18:877-882.
21. Mehta MC, Jain AC, Billie M. J Cardiovasc Pharmacol 1998;31:930-936.
22. US Department of Health and Human Services. Seventh Special Report to the US Congress on Alcohol and Health. Washington, DC: National Institute on Alcohol Abuse and Alcoholism (US Department of Health and Human Services Publication ADM 90, 1656); 1990.
23. US Environmental Protection Agency. Respiratory Health Effects of Passive Smoking, Lung Cancer and Other Disorders. Washington, DC: US Environmental Protection Agency (US Environmental Protection Agency Publication 600, 6-90/006F); 1992.
24. Weksler BB, Moore A, Tepler J. Hematology. In: Andreoli TE, Carpenter CCJ, Plum F, Smith LHJ, editors. Cecil essentials of medicine. Philadelphia: WB Saunders Co. 1990. p 341-363.
25. Del Boccio G, Lapenna D, Porreca E, Pennelli A, Savini F, Feliciani P, Ricci G, Cuccurullo F. Atherosclerosis 1990;81:127-135.
26. Hoffmann D, Rivenson A, Hecht SS. Crit Rev Toxicol 1996;26:199-211.
27. Maser E. Trends Pharmacol Sci 1997;18:270-275.
28. McGinnis JM, Foege WH. JAMA 1993;270:2207-2212.
29. Pryor WA, Stone K. Ann NY Acad Sci 1993;686:12-27, discussion 27-18.
30. Kessler DA, Witt AM, Barnett PS, Zeller MR, Natanblut SL, Wilkenfeld JP, Lorraine CC, Thompson LJ, Schultz WB. N Engl J Med 1996;335:988-994.
31. Shaw M, Mitchell R, Dorling D. BMJ 2000;320:53.
32. Sastry BV, Chance MB, Singh G, Horn JL, Janson VE. Pharmacology 1995;50:128-136.
33. Sastry BV, Gujrati VR. Ann NY Acad Sci 1994;714:312-314.
34. Buccafusco JJ, Terry Jr, AV. Life Sci 2003;72:2931-2942.
35. Gilman AG, Goodman LS, Rall TW, Murad F. Goodman and Gilman's The pharmacological basis of therapeutics. MacMillan Publishing Co; 1980.
36. Anandatheerthavarada HK, Williams JF, Wecker L. J Neurochem 1993;60:1941-1944.
37. Ashakumary L, Vijayammal PL. J Ecotoxicol Environ Monit 1991;1:283-290.
38. Bhagwat SV, Vijayasarathy C, Raza H, Mullick J, Avadhani NG. Biochem Pharmacol 1998;56:831-839.
39. Brigelius-Flohe R, Traber MG. Faseb J 1999; 13:1145-1155.
40. Altikat S, Ciftci M, Buyukokuroglu ME. Pol J Pharmacol 2002;54:67-71.
41. Beydemir S, Gulcin I, Kufrevioglu OI, Ciftci M. Pol J Pharmacol 2003;55:787-792.
42. Beydemir S, Kulacoglu DN, Ciftci M, Kufrevioglu OI. Eur J Ophthalmol 2003;13:155-161.
43. Beydemir S, Kulacoglu DN, Ciftci M, Kufrevioglu OI. Turk J Chem 2003;27:601-608.
44. Buyukokuroglu ME, Altikat S, Ciftci M. Alcohol Alcohol 2002;37:327-329.
45. Ciftci M, Senyayla F, Ozdemir H, Buyukokuroglu ME. Pol J Pharmacol 2002;54:673-679.
46. Ciftci M, Bilici D, Kufrevioglu OI. Pharmacol Res 2001;44:7-11.
47. Ciftci M, Kufrevioglu OI, Gundogdu M, Ozmen I. Pharmacol Res 2000;41:109-113.
48. Ciftci M, Demir Y, Ozmen I, Atici O. J Enzyme Inhib Med Chem 2003;18:71-76.
49. Odcikin E, Ozdemir H, Ciftci M, Capoglu I. Endocr Res 2002;28:61-68.
50. Beutler E. Red cell metabolism: A manual of biochemical method. New York: Grune and Stration; 1984.
51. Bradford MM. Anal Biochem 1976;72:248-254.
52. Gupta BL, Nehal M, Baquer NZ. Indian J Exp Biol 1997;35:792-795.
53. Friguet B, Stadtman ER, Szweda LI. J Biol Chem 1994;269:21639-21643.
54. Grossman S, Budinsky R, Jollow D. J Pharmacol Exp Ther 1995;273:870-877.
55. Husain K, Scott BR, Reddy SK, Somani SM. Alcohol 2001;25:89-97.
56. Gumustekin K, Altinkaynak K, Timur H, Taysi S, Oztasan N, Polat MF, Akcay F, Suleyman H, Dane S, Gul M. Hum Exp Toxicol 2003;22:425-431.
57. Suleyman H, Gumustekin K, Taysi S, Keles S, Oztasan N, Aktas O, Altinkaynak K, Timur H, Akcay F, Akar S, Dane S, Gul M. Biol Pharm Bull 2002;25:1133-1136.
58. Zhang S, Day I, Ye S. Atherosclerosis 2001;154:277-283.
59. Jang MH, Shin MC, Lee TH, Kim YP, Jung SB, Shin DH, Kim H, Kim SS, Kim EH, Kim CJ. Neurosci Lett 2002;329:141-144.
60. Lee TH, Jang MH, Shin MC, Lim BV, Choi HH, Kim H, Kim EH, Kim CJ. Nutr Res 2002;22:1445-1452.
61. Vanscheeuwijck PM, Teredesai A, Terpstra PM, Verbeeck J, Kuhl P, Gerstenberg B, Gebel S, Carmines EL. Food Chem Toxicol 2002;40:113-131.
62. Hu D, Cao K, Peterson-Wakeman R, Wang R. Biochem Biophys Res Commun 2002;297:729-736.
63. Abreu-Villaca Y, Seidler FJ, Slotkin TA. Brain Res 2003;988:164-172.
64. Supuran CT, Scozzafava A, Casini A. Med Res Rev 2003;23:146-189.